Evidence map›Paper›PMID 21510770›Full record

ReviewOphthalmic genetics2011

Allelic and phenotypic heterogeneity in ABCA4 mutations.

Tomas R Burke, Stephen H Tsang

Abstract readReview
In one paragraph

Review in Ophthalmic genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. More insights from Abca4The Journal of biological chemistry · 2026
    Article
  5. Article
  6. Stargardt macular dystrophy and therapeutic approaches.The British journal of ophthalmology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. A five-year follow-up ofMolecular vision · 2022
    Article
  11. Association ofInternational journal of environmental research and public health · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Tomas R BurkeDepartment of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University, New York 10032, USA.
Stephen H Tsang
Columbia University · USSchlumberger (Ireland) · IE

Funding

Toward mechanism- and gene-based therapies for retinal degenerationR01EY018213 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stephen H Tsang · 2008 to 2026
$6.6M
NEI NIH HHS R01 EY018213Wellcome Trust
6 · The paper itself

Abstract

Since the discovery of the ABCA4 gene as the cause of autosomal recessive Stargardt disease/fundus flavimaculatus much has been written of the phenotypic variability in ABCA4 retinopathy. In this review the authors discuss the findings seen on examination and the disease features detected using various clinical tests. Important differential diagnoses are presented and unusual presentations of ABCA4 disease highlighted.

Indexed as

Genetic HeterogeneityMutationAllelesATP-Binding Cassette TransportersDiagnosis, DifferentialElectroretinographyFluorescein AngiographyHumansPhenotypeRetinal DiseasesTomography, Optical CoherenceVisual Field TestsABCA4 protein, humanATP-Binding Cassette Transporters

Identifiers

PMID21510770
PMCPMC3155666
OpenAlexW2147560227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.